Concepedia

Subha Saha

SS

Statistics

Publications

5

Citations

114

H-Index

5

Active since

2019

Affiliations

Institute of Life Sciences(Current)

Regional Centre for Biotechnology

New York University

All India Institute of Medical Sciences Bhubaneswar

Subha Saha is an author at Institute of Life Sciences specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2019–2023

5

Publications

5

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Peter G. Miller, Adam S. Sperling, Christina Mayerhofer et al. · Blood · 2023 · 46 citations · Full text

, , +16

Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia

Subha Saha, Krushna Chandra Murmu, Mayukh Biswas et al. · Frontiers in Oncology · 2019 · 23 citations · Full text

, , +17

Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach

Sohini Mukhopadhyay, Subha Saha, Subhayan Chakraborty et al. · PLoS ONE · 2022 · 18 citations · Full text

, , +17

<scp>MIF</scp> confers survival advantage to pancreatic <scp>CAFs</scp> by suppressing interferon pathway‐induced p53‐dependent apoptosis

Voddu Suresh, Pujarini Dash, Sujit Suklabaidya et al. · The FASEB Journal · 2022 · 16 citations

, , +17

SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms

Subha Saha, Priyanka Samal, Swati Madhulika et al. · Blood Advances · 2022 · 11 citations · Full text

, , +16

1–5 of 5